̽»¨¾«Ñ¡

Programme

8:00-8:05 CT / 3:00-3:05 CET- Welcome

Matthew P. Goetz, M.D. Professor of Oncology and Pharmacology Deputy Director of Translational Research, Mayo Clinic Comprehensive Cancer Center and Elias Arnér,M.D., Ph.D. Professor and Director of Cancer Research, Ì½»¨¾«Ñ¡

8:05–8:15 CT / 3:05–3:15 CET- Introductory Remarks 

Martin Bergö, M.D., Ph.D. Professor of Molecular Medicine Vice-President, ̽»¨¾«Ñ¡ 

8:15–8:45 CT / 3:15–3:45 CET - Development of extracellular vesicle biomarkers for CART cell functions in lymphoma

Saad Kenderian, M.B., Ch.B. and Stephan Mielke, M.D. 

8:45–9:15 CT / 3:45–4:15 CET - Discovery of new therapies for the treatment of estrogen receptor positive breast cancer

John R. Hawse, Ph.D. and Oscar Fernandez-Capetillo, Ph.D.

9:15–9:30 CT / 4:15–4:30 CET- Break

9:30–10:00 CT / 4:30–5:00 CET - Development of novel computational approaches to interpret and leverage multi-organ single-cell spatial profiling for comprehensive characterization of the triple-negative breast cancer tumor microenvironment

Roberto A. Leon Ferre, M.D., JC Villasboas Bisneto, M.D., Jean Hausser, M.D.

10:00–10:30 CT / 5:00–5:30 CET - Clinical Characterization of Inherited Variants in Breast Cancer Predisposition Genes 

Fergus Couch, Ph.D. 

10:30–11:00 CT / 5:30–6:00 CET- Modern breast cancer surgery - is less more?   

Jana De Boniface, M.D., Ph.D.

11:00–11:15 CT / 6:00–6:15 CET- Closing Remarks

Matthew P. Goetz, M.D. and Elias Arnér, Ph.D.